JPWO2024232425A1 - - Google Patents
Info
- Publication number
- JPWO2024232425A1 JPWO2024232425A1 JP2025519465A JP2025519465A JPWO2024232425A1 JP WO2024232425 A1 JPWO2024232425 A1 JP WO2024232425A1 JP 2025519465 A JP2025519465 A JP 2025519465A JP 2025519465 A JP2025519465 A JP 2025519465A JP WO2024232425 A1 JPWO2024232425 A1 JP WO2024232425A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023078256 | 2023-05-11 | ||
| PCT/JP2024/017344 WO2024232425A1 (ja) | 2023-05-11 | 2024-05-10 | プロスタグランジンＦ２α誘導体の含有率低下が抑制されている製品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2024232425A1 true JPWO2024232425A1 (da) | 2024-11-14 |
Family
ID=93430138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025519465A Pending JPWO2024232425A1 (da) | 2023-05-11 | 2024-05-10 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2024232425A1 (da) |
| CN (1) | CN121057582A (da) |
| WO (1) | WO2024232425A1 (da) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008189567A (ja) * | 2007-02-01 | 2008-08-21 | Nippon Tenganyaku Kenkyusho:Kk | プロスタグランジン水性点眼剤 |
| EP2127638A1 (en) * | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
| WO2018181294A1 (ja) * | 2017-03-27 | 2018-10-04 | 興和株式会社 | 医薬製剤 |
| JP7191541B2 (ja) * | 2018-04-26 | 2022-12-19 | 興和株式会社 | 医薬製剤 |
| JP2021177839A (ja) * | 2020-05-12 | 2021-11-18 | 藤森工業株式会社 | 点眼剤容器 |
| JP7758477B2 (ja) * | 2020-06-15 | 2025-10-22 | Ｍｃｐｐイノベーション合同会社 | 熱可塑性樹脂組成物及びそれからなる成形体 |
| JP7584938B2 (ja) * | 2020-08-03 | 2024-11-18 | Ｍｃｐｐイノベーション合同会社 | 医療用成形体 |
| JP7565751B2 (ja) * | 2020-10-22 | 2024-10-11 | Ｍｃｐｐイノベーション合同会社 | 熱可塑性樹脂組成物及びそれからなる成形体 |
| JP2022120120A (ja) * | 2022-06-13 | 2022-08-17 | 東亜薬品株式会社 | 眼科用水性組成物及びプロスタグランジンＦ２α誘導体の含量の低下を抑制する方法 |
-
2024
- 2024-05-10 JP JP2025519465A patent/JPWO2024232425A1/ja active Pending
- 2024-05-10 WO PCT/JP2024/017344 patent/WO2024232425A1/ja not_active Ceased
- 2024-05-10 CN CN202480030304.4A patent/CN121057582A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024232425A1 (ja) | 2024-11-14 |
| CN121057582A (zh) | 2025-12-02 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251128 |